Business Wire

IL-WEBER

18.1.2022 15:07:08 CET | Business Wire | Press release

Share
Weber Inc. Transforms Outdoor Cooking With Innovative 2022 Product Portfolio

Weber Inc. (NYSE:WEBR), the global leader in outdoor cooking innovation, technology, and products, today unveiled the first three new products in its 2022 grilling portfolio. Designed to fuse the best in smart technology, high-quality materials, performance engineering, and craftsmanship, the 2022 GENESIS Smart Gas Grill, 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, and all-new WEBER CRAFTED Outdoor Kitchen Collection take cooking outdoors to new levels of food discovery and exploration.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220118005538/en/

“Our product lineup for the upcoming barbecue season pushes the boundaries of the types of cooking that can be done outdoors, including bringing popular methods like flat top cooking and baking right to a WEBER grill,” said Jennifer Bonuso, Senior Vice President and General Manager, Global Product Management of Weber. “These new products are shaped by insights from grilling enthusiasts around the world, who crave to create more when they cook outside. We answered that desire by bringing together our best smart technology, new features, and a unique grillware collection.”

ABOUT THE NEW WEBER CRAFTED OUTDOOR KITCHEN COLLECTION

The WEBER CRAFTED Outdoor Kitchen Collection is a line of exclusive, high-quality, interchangeable grillware that enables a variety of different cooking methods. Outdoor cooks can use traditional grill grates or switch in a flat-top surface to open up a world of new foods at the grill, like eggs, pancakes, smashed burgers, and more. Exchange the grates for a baking stone for pizzas, crispy flatbreads, and cookies, or use rotisserie skewers for kabobs and roasted chicken. The Collection transforms the grill into a versatile, complete outdoor kitchen.

The WEBER CRAFTED line features six cooking pieces -- each providing a large cooking surface -- that facilitate steaming, baking, roasting, searing, or flat top cooking right at the grill. The complete grillware Collection consists of a Dual-Sided Sear Grate, Flat Top, Glazed Baking Stone, Roasting Basket, Wok & Steamer, and Rotisserie Skewer pieces. Additionally, it includes specially designed grates and an insert that allows the grillware pieces to be easily changed out on a WEBER gas, charcoal, or pellet grill.

Each WEBER CRAFTED item is sold separately.

ABOUT THE NEW WEBER GENESIS SMART GAS GRILL

The 2022 GENESIS Smart Gas Grill, Weber’s most advanced gas grill in 15 years, creates the ultimate culinary experience for grilling enthusiasts.

Built with high-quality materials, ingenuity, and the craftsmanship Weber is known for, the 2022 GENESIS grill is feature-packed to bring a complete outdoor kitchen experience to any outside space, including:

  • WEBER CRAFTED Outdoor Kitchen Collection-ready with cooking grates specially designed to accommodate the WEBER CRAFTED grate insert and grillware pieces (sold separately) and unlock a wide range of cooking options at the grill.
  • Integrated WEBER CONNECT smart grilling technology creates perfectly grilled food through real-time food temperature alerts, reminders, and flip and serve notifications at the grill or on the phone. With the WEBER CONNECT App, outdoor cooks can stay connected to their grill while taking care of guests, watching the game, or enjoying a drink.
  • Proprietary PUREBLU high heat burners are designed to produce the most efficient, even flame for consistent, precise heat and reliable ignition.
  • Extra-large SEAR ZONE allows outdoor cooks to sear multiple food items simultaneously.
  • Extra-large Prep and Serve Table accommodates more trays and dishes than previous GENESIS models.
  • NIGHTVISION motion-sensor, under-the-lid LED lights illuminate the entire grilling surface - from the side table to the grates. This patent-pending lighting system is ideal for early morning, dusk, and nighttime outdoor cooking.
  • Expandable, Top Cooking Grate increases the overall available grilling space of the 2022 GENESIS grill, providing extra room to cook appetizers, sides, or main course dishes, all at the same time.

The 2022 GENESIS gas grill line includes several different three and four-burner models. In addition, models are available in porcelain-enamel or stainless steel finishes.

ABOUT THE NEW SMOKEFIRE WOOD PELLET GRILL, STEALTH EDITION

The 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, brings a sleek, distinctive black-on-black aesthetic to Weber’s all-in-one SMOKEFIRE pellet grilling experience, which centers on exceptional wood fired flavor through both high heat searing and low and slow smoking,

The 2022 SMOKEFIRE Grill, STEALTH Edition, includes:

  • All-black exterior styling.
  • WEBER CRAFTED Outdoor Kitchen Collection - ready to open up the types of meals that can be made on a pellet grill, adding the ability to roast, steam, and even stir-fry.
  • WEBER CONNECT smart grilling technology
  • Built-in grill lighting illuminates the cooking grate for those extended evening or early morning cooks.
  • A top cooking grate provides a large, second level of grilling capacity.
  • Porcelain-enamel construction retains heat, even in cooler temperatures, and helps prevent rust and cracking.

The 2022 SMOKEFIRE Wood Fire Pellet Grill, STEALTH Edition series includes two models. Available models will vary by geographic region.

And to help inspire mealtime, Weber recently updated its popular WEBER CONNECT App with recipes, recipe collections, and additional cook programs that feature dishes and meal ideas that outdoor cooks can easily create with these new products. Weber owners can explore recipes for simple fare such as Balsamic Glazed Pork Chops with Peach Salsa and Grilled Carrots with Nutmeg Butter, to more sophisticated dishes such as Lemon-Ginger Tofu Steaks with Carrot and Cashew Salad or Chargrilled Oysters with Creole Remoulade Sauce and Grill Corn on the Cob with Basil Parmesan Butter.

The full 2022 GENESIS Gas Grill line and WEBER CRAFTED Outdoor Kitchen Collection will be available in the Americas and Europe leading up to the Spring barbecuing season from Weber websites and retail partners worldwide. In North America, consumers can purchase select models of the 2022 Genesis gas grill line and WEBER CRAFTED Collection online and in-store now. In addition, the 2022 SMOKEFIRE Wood Fired Pellet Grill, STEALTH Edition, will be available for purchase this Spring.

ABOUT WEBER INC.

Weber Inc. headquartered in Palatine, Ill., is the world’s leading barbecue brand. The Company’s founder George Stephen, Sr., established the outdoor cooking category when he invented the original kettle charcoal grill nearly 70 years ago. Weber offers a comprehensive, innovative product portfolio, including charcoal, gas, pellet and electric grills, smokers, and accessories designed to help outdoor cooking enthusiasts discover what’s possible. In 2021, the Company acquired June Life Inc., a smart appliance and technology company, to accelerate the development of its Weber Connect technology and digital products. In addition, Weber recently launched 1952 Ventures , a subsidiary designed to accelerate new growth platforms and brand extensions for the Company in the areas of product, technologies, and partnerships. Weber offers its barbecue grills and accessories, services, and experiences to a passionate community of millions across 78 countries.

WEBER®, GENESIS®, SMOKEFIRE®, and WEBER CONNECT® are U.S. registered trademarks; STEALTH; NIGHTVISION, PUREBLUE, and SEAR ZONE are trademarks; all owned by Weber-Stephen Products LLC.

FUTURE STATEMENTS

This press release contains various “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which represent Weber’s expectations or beliefs concerning future events. In some cases, you can identify these statements by forward-looking words such as “may,” “might,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue,” the negative of these terms and other comparable terminology. There are important factors that could cause our actual results, level of activity, performance or achievements to differ materially from the results, level of activity, performance or achievements expressed or implied by the forward-looking statements, including those factors listed in the Company's filings with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

Our future results could be affected by a variety of other factors, including uncertainty of the magnitude, duration, geographic reach, impact on the global economy and current and potential travel restrictions of the COVID-19 outbreak, the current, and uncertain future, impact of the COVID-19 outbreak on our business, growth, reputation, prospects, financial condition, operating results (including components of our financial results), and cash flows and liquidity, risks relating to any unforeseen changes to or effects on liabilities, future capital expenditures, revenues, expenses, earnings, synergies, indebtedness, financial condition, losses and future prospects, the ability to realize the anticipated benefits and synergies from business acquisitions in the amounts and at the times expected, the impact of competitive conditions, the effectiveness of pricing, advertising, and promotional programs; the success of innovation, renovation and new product introductions; the recoverability of the carrying value of goodwill and other intangibles, the success of productivity improvements and business transitions, commodity and energy prices, transportation costs, labor costs, disruptions or inefficiencies in supply chain, the availability of and interest rates on short-term and long-term financing, the levels of spending on systems initiatives, properties, business opportunities, integration of acquired businesses, and other general and administrative costs, changes in consumer behavior and preferences, the effect of U.S. and foreign economic conditions on items such as interest rates, statutory tax rates, currency conversion and availability, legal and regulatory factors including the impact of any product recalls; and business disruption or other losses from war, pandemic, terrorist acts or political unrest.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye